CRISPR-Cas9 is one of the biggest discoveries of the 21st century. Since it was developed in 2012, this gene-editing tool has revolutionized biology research, making it easier to study disease and ...

The National Institutes of Health has awarded an Oklahoma Medical Research Foundation scientist a $4.1 million grant to study ...

“Two chromosomal inversions of different sizes were induced using CRISPR/Cas9 to move heterochromatic ... professor at the Karlsruhe Institute of Technology and an author of the paper ...

The epigenetic state of chromatin, gene activity, and chromosomal positions are interrelated. A research team from the IPK ...

It’s a new way to create “bi-paternal” mice that can survive to adulthood—but human applications are still a long way off.

Experts hailed exciting news for some people with sickle cell disease in England as the health watchdog decided to grant ...

CRISPR Therapeutics AG (NASDAQ:CRSP), a leading biotechnology company specializing in gene-based medicines with a market capitalization of $3.45 billion, stands at a critical juncture as it navigates ...

Similarly, in 2020, the prize went to developers of CRISPR, “genetic scissors” for editing DNA ... “We're addressing a significant component of the waste stream with this technology. That'd make a ...

CRISPR-Cas9 technology has the potential to enhance photosynthetic efficiency and increase crop yields. CRISPR-Cas9 is a gene editing process where genetic engineers can target specific genes in the ...